Twist Bioscience stock trades up to $103.74 as Twist Bioscience supports plant genome DNA insertion study

Twist Bioscience stock trades up to $103.74 as Twist Bioscience supports plant genome DNA insertion study
Twist Bioscience up 0.84% today

Twist Bioscience announced the optimization of R2 retroelement complexes for DNA insertion into plant genomes.

Highlights

  • TWST shows strong bullish momentum, trading significantly above all major moving averages with buyers firmly in control.
  • The stock sits at the top of its weekly range following a 4.17% rise, with sustained upward momentum and minimal signs of reversal.
  • TWST is expected to consolidate between $99.50 and $108.00 next week, with a high probability of further gains unless price falls below $99.50.

The authors of the related research chose Twist DNA to support their work. The study appears in Nature Biotechnology.

Bullish positioning as price clears major moving average supports

TWST is trading at $103.74, well above the MA-20 ($81.96), MA-50 ($68.08), and MA-200 ($45.59), which confirms strong bullish momentum across all timeframes. The Ichimoku Kijun on D1 stands at $80.39, serving as immediate support now that the price is above it. Near-term support is found at the MA-20 ($81.96), with key support at MA-50 ($68.08). Immediate resistance lies at the recent weekly high ($104.11), while the 52-week high also acts as key resistance.

Overbought momentum persists as buyers dominate weekly range

Momentum indicators on D1 are robust, with MACD and ADX both signaling strong buyer dominance. RSI (79.00), Stoch RSI (98.24), and CCI (137.13) all indicate heavily overbought conditions, suggesting short-term exhaustion risk. BBP reflects continued intraday buyer pressure. The Awesome Oscillator is also bullish, echoing the prevailing uptrend. TWST is trading at $103.74, up from $99.84 a week ago, a 4.17% gain. The price is now at the very top of its weekly range, with weekly volatility at 13.31%. The tone is one of sustained momentum after a strong advance, with little sign of consolidation or reversal so far.

Upside favored as breakout risk outweighs reversal odds

Looking ahead, the expected price range for the next week is $99.50 to $108.00, which sits close to the upper end of the 52-week range and keeps within a realistic band given recent volatility. Based on bullish signals from MA-50-W1, RSI-W1, ADX-W1, and MACD-W1, there is a very high probability (more than 80%) of further gains, while a downward move is much less likely. Baseline scenario: TWST consolidates between $99.50 and $108.00. A bullish breakout above $104.11 could open the way toward $108.00. A bearish reversal below $99.50 would expose the stock to a pullback toward the $95 area but appears unlikely given the current momentum and lack of immediate bearish triggers.

Previously it was reported that Twist Bioscience was exhibiting strong bullish momentum, with technical analysis suggesting further upside potential. This article updates the outlook by highlighting current conditions and points to a key level traders should watch as the situation evolves.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.